Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Journey Medical (DERM) Cost of Revenue (2020 - 2026)

Journey Medical filings provide 6 years of Cost of Revenue readings, the most recent being $5.4 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 16.24% to $5.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.9 million, a 0.21% change, with the full-year FY2025 number at $20.9 million, changed 0.22% from a year prior.
  • Cost of Revenue hit $5.4 million in Q4 2025 for Journey Medical, down from $5.8 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $11.2 million in Q3 2021 to a low of $2.2 million in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $6.2 million (2023), compared with a mean of $6.4 million.
  • Biggest five-year swings in Cost of Revenue: soared 230.48% in 2021 and later tumbled 70.87% in 2023.
  • Journey Medical's Cost of Revenue stood at $9.5 million in 2021, then decreased by 18.97% to $7.7 million in 2022, then tumbled by 70.87% to $2.2 million in 2023, then surged by 108.19% to $4.7 million in 2024, then increased by 16.24% to $5.4 million in 2025.
  • The last three reported values for Cost of Revenue were $5.4 million (Q4 2025), $5.8 million (Q3 2025), and $4.9 million (Q2 2025) per Business Quant data.